09.25.2018 Issue 420

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Value in Health Issues Calls for Papers

Monday, September 24th

The International Society for Pharmacoeconomics and Outcomes Research’s publication, Value in Health, has issued a call for papers as it prepares to spotlight in a special theme health technology assessment in health care decision making.

CVS Data: Program Helps Cut Out-of-Pocket Costs

Opinions Divided on CVS Program

Amazon-JPM-Berkshire Health Venture Hires Monitor Group

Mass Resignation Rocks Board of Cochrane Collaboration

New Medicare Advantage Tool Hampers Patient Choice

Machine Learning in Literary Reviews

Analysis Looks at How ICER's QALYs Could Impact Pricing in US

UK Ruling Could Save NHS 'Hundreds of Millions' Annually

Researchers: Invest in 'Precision Health' to Boost Care for High-Need, High-Cost Patients

Group of Companies Eyes Private Blockchain

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director Real World Evidence (RWE) and Epidemiology

Associate Director/ Director, Medical Affairs- HEOR

Watson Health - Outcomes Research Leader (HEOR)

Industry Spotlight

Conferences Webinars
9th Clinical Biomarkers and World CDx Boston
    October 2-5, Boston, MA

8th EPP Life Sciences Pricing Forum
    October 3-5, Montreux, Switzerland

2018 Hospital Observation Patient Management Summit
    October 4-5, Chicago, IL

InnoHEALTH 2018
    October 5-6, Gurugram, India

European Epidemiological Forum, 2018
   October 8, Zurich, Switzerland

RWE for Medical Devices in the Age of Big Data, Machine Learning, and 21st Century Cures
    September 25

Beyond Controlling for Confounding: Design Strategies to Avoid Selection Bias and Improve Efficiency in Observational Studies
    September 27

Constrained Optimization Methods in Health Services Research — An Introduction
   October 2

ICER Reports’ Impact on US Drug Coverage Decisions: Passing Fad or Game Changer?
    October 9

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL  Xcenda
        OM1Parexel   Jefferson   Dymaxium   Precision Xtract
          Pharmerit    eMax Health   SciformixEvidence Partners
          ICON    Truven